Healthcare -
Biotechnology - NASDAQ - US
$ 0.7113
6.24 %
$ 42.1 M
Market Cap
-0.89
P/E
ELEV - COST OF REVENUE
Cost of Revenue ELEV - Elevation Oncology, Inc.
39 K
LAST VALUE
47.20%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR